|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/58 | |
| A61K 9/16 | |||
| A61K 47/48 | |||
| A61K 9/10 | |||
| A61K 9/20 |
| (11) | Patento numeris | 2018160 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07753217.4 |
| Europos patento paraiškos padavimo data | 2007-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-01-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-12-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/006572 |
| Data | 2007-03-15 |
| (87) | Numeris | WO 2007/109104 |
| Data | 2007-09-27 |
| (30) | Numeris | Data | Šalis |
| 783181 P | 2006-03-16 | US |
| (72) |
MEHTA, Ketan, US
TU, Yu-hsing, US
|
| (73) |
Tris Pharma, Inc.,
2033 Route 130, Suite D, Monmouth Junction, NJ 08852,
US
|
| (54) | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES |
| MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES |